Fish oil pills could help fight prostate cancer, new study hints
NCT ID NCT02333435
First seen Nov 20, 2025 · Last updated Jun 22, 2026 · Updated 35 times
Summary
This phase 2 trial tests whether taking omega-3 (EPA) supplements can reduce inflammation and slow cancer cell growth in men with high-risk prostate cancer who choose surgery. 130 participants will take either EPA capsules or a placebo for 14 months, starting before surgery. Researchers will measure changes in tumor growth markers and quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Centre de Recherche Clinique et Evaluative en Oncologie - Hotel Dieu de Quebec
Québec, Quebec, G1R 3S1, Canada
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Omega-3 (EPA) dietary supplement
What this could lead to
If it works, this could point toward a simple dietary supplement to help control prostate cancer growth and improve quality of life after surgery.
What could go wrong
This is an early phase 2 trial with only 130 participants. The supplement may not show a clear benefit, and results may not apply to all prostate cancer patients.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.